Etanercept therapy alters monocyte subsets and improves DAS28-CRP in rheumatoid arthritis patients.
High monocyte levels predict better RA drug response
This prospective cohort study evaluated etanercept therapy in rheumatoid arthritis patients over 12 and 24 weeks. Results showed significant…
A simple blood test may soon help doctors know which RA patients will respond to a widely used drug — sparing others months of wasted time a…
Subcutaneous etanercept rapidly alleviated pain and inflammation in 12 acute gout patients compared to methylprednisolone.
Small study finds etanercept may help acute gout pain like steroids
This single-center, prospective, randomized, open-label study evaluated subcutaneous etanercept versus intravenous methylprednisolone in 12 …
A small study found etanercept provided rapid pain relief for acute gout flares that matched standard steroid treatment with no serious side…